Latest Drug Approvals news
FDA to Fast-Track 9 Experimental Drugs Under New Trump Program
posted October 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
posted October 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Zoryve for Atopic Dermatitis in Young Children
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
posted October 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
